Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...
Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court Johnson & Johnson convinced Delaware's highest court to throw out part of a $1 billion damages award for ...
Germany's justice ministry plans to present measures in the near future that would allow authorities to more effectively combat the use of artificial intelligence to manipulate images in ways that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback